Table 1:
Variable | N = 153 patients |
---|---|
Age (years), mean (SD) | 58.5 (11.4) |
Male, n (%) | 141 (92) |
Race, n (%) | |
White | 99 (65) |
Non-white | 54 (35) |
Duration since gout diagnosis (years), mean (SD) | 14.9 (10.3) |
Total daily allopurinol dose, n (%) | |
300mg | 125 (82) |
>300mg | 28 (18) |
Duration of allopurinol treatment (years), mean (SD) | 5.1 (6.9) |
SU level, n (%) | |
<6 mg/dL | 78 (51) |
≥6 mg/dL | 75 (49) |
Subcutaneous tophi, n (%) | 48 (31) |
SU = serum urate; SD = standard deviation